June 2, 2018
Genitourinary cancer - ASCO18

Top ASCO 2018 Abstracts To Watch Out For In Genitourinary Cancers

Abstract 5003: Olaparib (Lynparza) combined with abiraterone (Zytiga) in patients with metastatic castration-resistant prostate cancer (mCRPC): a randomized phase II trial Conclusion: This is the first trial to show clinical benefit (increase in PFS) for mCRPC pts treated with a PARP inhibitor combined with abiraterone, regardless of HRRm status. Safety […]